AlphaYouTK
Congress trade
Rep. Thomas Kean (R-NJ) bought $1K-$15K of Abbott Laboratories (ABT) stock
Thomas Kean, U.S. Representative (R-NJ), disclosed a purchase of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Feb 19, 2026.
The trade happened on Jan 29, 2026, 21 days before it was made public.
ABT has moved -2.9% since the trade date, from $106.09 to $102.98 (Sep 21, 2026 close).
- Traded
- Jan 29, 2026
- Disclosed
- Feb 19, 2026
- Filing delay
- 21 days
- Price since
- -2.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (5)
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.